Lexicon Pharmaceuticals, Inc. (LXRX) financial statements (2022 and earlier)

Company profile

Business Address 2445 TECHNOLOGY FOREST BLVD.
THE WOODLANDS, TX 77381
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments87152272160311347521
Cash and cash equivalents6412636806247203
Short-term investments232623680249300318
Receivables00576571
Inventory, net of allowances, customer advances and progress billings  452  
Inventory  452  
Other current assets25534410
Total current assets:89158338173322358532
Noncurrent Assets
Property, plant and equipment101416181921
Intangible assets, net (including goodwill)45456495969898
Goodwill45454545454545
Intangible assets, net (excluding goodwill)  2050525353
Other noncurrent assets2120003
Total noncurrent assets:484680111115118122
TOTAL ASSETS:137204418284437476655
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22355432708544
Accounts payable951218585320
Accrued liabilities13304214123225
Debt 1211114162
Deferred revenue and credits406376
Other undisclosed current liabilities   3   
Total current liabilities:22476537124165123
Noncurrent Liabilities
Long-term debt and lease obligation, including:  124423285104
Long-term debt, excluding current maturities  23424423285104
Other undisclosed long-term debt and lease obligation  (233)    
Liabilities, other than long-term debt11162968142
Deferred revenue and credits2249109
Deferred tax liabilities, net661919
Other liabilities11100114
Other undisclosed noncurrent liabilities  23324   
Total noncurrent liabilities:11235274260154246
Total liabilities:2347301311384318369
Stockholders' equity
Stockholders' equity attributable to parent114156117(26)52157286
Common stock0000000
Treasury stock, value(8)(5)(4)(3)(2)(3)(3)
Additional paid in capital1,6091,5611,4621,4481,4361,4111,398
Accumulated other comprehensive income (loss)(0)(0)0(0)(0)(0)(0)
Accumulated deficit(1,488)(1,400)(1,341)(1,472)(1,381)(1,250)(1,109)
Total stockholders' equity:114156117(26)52157286
TOTAL LIABILITIES AND EQUITY:137204418284437476655

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues024322639083130
Revenue, net9083130
Cost of revenue
(Cost of Goods and Services Sold)
 (2)(3)(2)(2)  
Gross profit:022319618883130
Operating expenses(87)(204)(181)(166)(227)(220)(129)
Other undisclosed operating income 135322  
Operating income (loss):(87)(48)141(103)(137)(137)1
Nonoperating income
(Other Nonoperating income)
0334221
Interest and debt expense(1)(14)(21)(21)(7)(7)(7)
Income (loss) from continuing operations before income taxes:(88)(59)124(121)(142)(141)(5)
Income tax benefit 06 13  
Income (loss) from continuing operations:(88)(58)130(121)(129)(141)(5)
Loss from discontinued operations (12)     
Income (loss) before gain (loss) on sale of properties:(88)(71)130(121)(129)(141)(5)
Other undisclosed net income 120    
Net income (loss) available to common stockholders, basic:(88)(59)130(121)(129)(141)(5)
Dilutive securities, effect on basic earnings per share(88)(59)135    
Net income (loss) available to common stockholders, diluted:(176)(117)265(121)(129)(141)(5)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(88)(59)130(121)(129)(141)(5)
Comprehensive income (loss):(88)(59)130(121)(129)(141)(5)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)00(0)0(0)
Comprehensive income (loss), net of tax, attributable to parent:(88)(59)130(120)(129)(141)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: